Female Fertility Cryopreservation Outcomes in Childhood Cancer: A Systematic Review
Issued Date
2024-01-01
Resource Type
ISSN
00223468
eISSN
15315037
Scopus ID
2-s2.0-85188458693
Journal Title
Journal of Pediatric Surgery
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Pediatric Surgery (2024)
Suggested Citation
Gillipelli S.R., Pio L., Losty P.D., Abdelhafeez A.H. Female Fertility Cryopreservation Outcomes in Childhood Cancer: A Systematic Review. Journal of Pediatric Surgery (2024). doi:10.1016/j.jpedsurg.2024.02.015 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/97789
Title
Female Fertility Cryopreservation Outcomes in Childhood Cancer: A Systematic Review
Author(s)
Corresponding Author(s)
Other Contributor(s)
Abstract
Background and aims: As survival rates in childhood cancer progress significantly, health outcomes in adulthood are pivotal to quality of life (QoL). Female patients undergoing chemotherapy and radiation for childhood cancer may experience adverse effects such as gonadotoxicity-related ovarian insufficiency. Ovarian tissue cryopreservation (OTC) is well studied in adults, but has only recently started to be explored in an effort to preserve fertility in young patients with childhood cancer. This systematic review aims to critically highlight contemporary outcomes of cryopreservation in female pediatric cancer patients. Methods: A systematic search was conducted in PubMed, Embase, and Web of Science databases to identify English-language full text articles and abstracts published between 2004 and 2022 describing cryopreservation among female children (0–21 years old) with cancer. Abstracts and full-text articles were screened for inclusion. Subsequently, data from eligible studies was extracted and analyzed. Descriptive statistics were utilized to estimate overall outcomes of cryopreservation. Results: Of 104 abstracts and 34 full-text articles, 12 studies were included. Data was collected from 7 world countries and involved some 612 pediatric and adolescent patients with malignant disease. Most common cancers included hematological malignant disease (81%), CNS nervous system malignant tumors (56%), and sarcomas (39%). Of the 6 studies with full reporting, OTC was undertaken in 501 patients, and 5.9% (30/501) of these patients underwent ovarian tissue transplantation (OTT). After OTT, 27 patients desired pregnancy and 33% (9/27) became pregnant. Six of these 9 patients (67%) had live births. Conclusions: Preliminary analysis showed that OTC has been successfully performed but not yet studied thoroughly in pediatric cancer patients in a longitudinal manner. This study has further shown that cryopreservation outcomes are mainly reported among adult patients living in high income countries, demonstrating a crucial need for long-term outcome studies focused on pediatric and prepuberal OTC, subsequent OTT, and potential pregnancy. This work is considered critical to aid standardize recommendations of fertility preservation in childhood cancer patients and to better inform the efficacy of these procedures to benefit patients in world nations of all fiscal income levels. Level of Evidence: Level III.